153 related articles for article (PubMed ID: 38880643)
1. Dysregulation of Immune Tolerance to Autologous iPSCs and Their Differentiated Derivatives.
Bogomiakova ME; Bogomazova AN; Lagarkova MA
Biochemistry (Mosc); 2024 May; 89(5):799-816. PubMed ID: 38880643
[TBL] [Abstract][Full Text] [Related]
2. iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors.
Bogomiakova ME; Sekretova EK; Anufrieva KS; Khabarova PO; Kazakova AN; Bobrovsky PA; Grigoryeva TV; Eremeev AV; Lebedeva OS; Bogomazova AN; Lagarkova MA
Stem Cell Res Ther; 2023 Apr; 14(1):77. PubMed ID: 37038186
[TBL] [Abstract][Full Text] [Related]
3. [At Home among Strangers: Is It Possible to Create Hypoimmunogenic Pluripotent Stem Cell Lines?].
Bogomiakova ME; Eremeev AV; Lagarkova MA
Mol Biol (Mosk); 2019; 53(5):725-740. PubMed ID: 31661474
[TBL] [Abstract][Full Text] [Related]
4. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.
Guha P; Morgan JW; Mostoslavsky G; Rodrigues NP; Boyd AS
Cell Stem Cell; 2013 Apr; 12(4):407-12. PubMed ID: 23352605
[TBL] [Abstract][Full Text] [Related]
5. Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.
Sackett SD; Brown ME; Tremmel DM; Ellis T; Burlingham WJ; Odorico JS
Transplant Rev (Orlando); 2016 Apr; 30(2):61-70. PubMed ID: 26970668
[TBL] [Abstract][Full Text] [Related]
6. Cells derived from iPSC can be immunogenic - yes or no?
Cao J; Li X; Lu X; Zhang C; Yu H; Zhao T
Protein Cell; 2014 Jan; 5(1):1-3. PubMed ID: 24474200
[TBL] [Abstract][Full Text] [Related]
7. Brief Report: Immune Microenvironment Determines the Immunogenicity of Induced Pluripotent Stem Cell Derivatives.
Todorova D; Kim J; Hamzeinejad S; He J; Xu Y
Stem Cells; 2016 Feb; 34(2):510-5. PubMed ID: 26439188
[TBL] [Abstract][Full Text] [Related]
8. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.
Araki R; Uda M; Hoki Y; Sunayama M; Nakamura M; Ando S; Sugiura M; Ideno H; Shimada A; Nifuji A; Abe M
Nature; 2013 Feb; 494(7435):100-4. PubMed ID: 23302801
[TBL] [Abstract][Full Text] [Related]
9. Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells.
Zhao T; Zhang ZN; Westenskow PD; Todorova D; Hu Z; Lin T; Rong Z; Kim J; He J; Wang M; Clegg DO; Yang YG; Zhang K; Friedlander M; Xu Y
Cell Stem Cell; 2015 Sep; 17(3):353-9. PubMed ID: 26299572
[TBL] [Abstract][Full Text] [Related]
10. Immunological Issues After Stem Cell-Based β Cell Replacement.
Sordi V; Pellegrini S; Piemonti L
Curr Diab Rep; 2017 Sep; 17(9):68. PubMed ID: 28726153
[TBL] [Abstract][Full Text] [Related]
11. The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies.
Scheiner ZS; Talib S; Feigal EG
J Biol Chem; 2014 Feb; 289(8):4571-7. PubMed ID: 24362036
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of induced pluripotent stem cells.
Zhao T; Zhang ZN; Rong Z; Xu Y
Nature; 2011 May; 474(7350):212-5. PubMed ID: 21572395
[TBL] [Abstract][Full Text] [Related]
13. Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate.
Morizane A; Doi D; Kikuchi T; Okita K; Hotta A; Kawasaki T; Hayashi T; Onoe H; Shiina T; Yamanaka S; Takahashi J
Stem Cell Reports; 2013; 1(4):283-92. PubMed ID: 24319664
[TBL] [Abstract][Full Text] [Related]
14. Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance.
de Almeida PE; Meyer EH; Kooreman NG; Diecke S; Dey D; Sanchez-Freire V; Hu S; Ebert A; Odegaard J; Mordwinkin NM; Brouwer TP; Lo D; Montoro DT; Longaker MT; Negrin RS; Wu JC
Nat Commun; 2014 May; 5():3903. PubMed ID: 24875164
[TBL] [Abstract][Full Text] [Related]
15. The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation.
Palomo AB; Lucas M; Dilley RJ; McLenachan S; Chen FK; Requena J; Sal MF; Lucas A; Alvarez I; Jaraquemada D; Edel MJ
J Clin Med; 2014 Apr; 3(2):373-87. PubMed ID: 26237380
[TBL] [Abstract][Full Text] [Related]
16. Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling.
Makino K; Long MD; Kajihara R; Matsueda S; Oba T; Kanehira K; Liu S; Ito F
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101945
[TBL] [Abstract][Full Text] [Related]
17. Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity.
Flahou C; Morishima T; Takizawa H; Sugimoto N
Front Immunol; 2021; 12():662360. PubMed ID: 33897711
[TBL] [Abstract][Full Text] [Related]
18. Generation of porcine induced pluripotent stem cells and evaluation of their major histocompatibility complex protein expression in vitro.
Park KM; Cha SH; Ahn C; Woo HM
Vet Res Commun; 2013 Dec; 37(4):293-301. PubMed ID: 23975685
[TBL] [Abstract][Full Text] [Related]
19. Enhanced wound healing promotion by immune response-free monkey autologous iPSCs and exosomes vs. their allogeneic counterparts.
Lu M; Peng L; Ming X; Wang X; Cui A; Li Y; Wang X; Meng D; Sun N; Xiang M; Chen S
EBioMedicine; 2019 Apr; 42():443-457. PubMed ID: 30926422
[TBL] [Abstract][Full Text] [Related]
20. The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives.
Liu X; Li W; Fu X; Xu Y
Front Immunol; 2017; 8():645. PubMed ID: 28626459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
